Last update 27 Sep 2025

AK2017

Overview

Basic Info

Drug Type
Fc fusion protein
Synonyms
AK 2017, AK-2017, AK2017
Target
GR
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases+ [2]
Active Indication
Growth hormone deficiencyIdiopathic short statureShort Stature, Idiopathic, Autosomal
Inactive Indication
Growth retardation
Originator Organization
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
Active Organization
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with AK2017
CTR20234263
/ RecruitingPhase 2
评价AK2017注射液治疗儿童矮小症（生长激素缺乏症、特发性身材矮小）有效性和安全性的随机、开放、阳性对照、多中心Ⅱ期临床试验
[Translation] A randomized, open, positive-controlled, multicenter phase II clinical trial to evaluate the efficacy and safety of AK2017 injection in the treatment of dwarfism (growth hormone deficiency, idiopathic short stature) in children
CTR20230023
/ CompletedPhase 1
评价 AK2017 注射液在健康成年受试者中单次给药的安全耐受性、药代动力学、初步药效动力学及免疫原性的 I 期临床试验
[Translation] Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, preliminary pharmacodynamics and immunogenicity of AK2017 injection after single administration in healthy adult subjects
100 Clinical Results associated with AK2017
Login to view more data
100 Translational Medicine associated with AK2017
Login to view more data
100 Patents (Medical) associated with AK2017
Login to view more data
100 Deals associated with AK2017
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Growth hormone deficiencyPhase 2
China
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
13 May 2024
Idiopathic short staturePhase 2
China
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
13 May 2024
Growth retardationPhase 1
China
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
14 Feb 2023
Short Stature, Idiopathic, AutosomalIND Approval
China
Anhui Anke Biotechnology (Group) Co., Ltd.Anhui Anke Biotechnology (Group) Co., Ltd.
05 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free